1
|
Morita K, Moriwaki T, Habe S, Taniguchi-Ikeda M, Hasegawa T, Minato Y, Aoi T, Maruyama T. Molecular Aggregation Strategy for Inhibiting DNases. JACS AU 2024; 4:2262-2266. [PMID: 38938790 PMCID: PMC11200219 DOI: 10.1021/jacsau.4c00210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/05/2024] [Revised: 04/03/2024] [Accepted: 04/03/2024] [Indexed: 06/29/2024]
Abstract
This study highlights the novel potential of molecular aggregates as inhibitors of a disease-related protein. Enzyme inhibitors have been studied and developed as molecularly targeted drugs and have been applied for cancer, autoimmune diseases, and infections. In many cases, enzyme inhibitors that are used for therapeutic applications interact directly with enzymes in a molecule-to-molecule manner. We found that the aggregates of a small compound, Mn007, inhibited bovine pancreatic DNase I. Once Mn007 molecules formed aggregates, they exhibited inhibitory effects specific to DNases that require divalent metal ions. A DNase secreted by Streptococcus pyogenes causes streptococcal toxic shock syndrome (STSS). STSS is a severe infectious disease with a fatality rate exceeding 30% in patients, even in this century. S. pyogenes disrupts the human barrier system against microbial infections through the secreted DNase. Until now, the discovery/development of a DNase inhibitor has been challenging. Mn007 aggregates were found to inhibit the DNase secreted by S. pyogenes, which led to the successful suppression of S. pyogenes growth in human whole blood. To date, molecular aggregation has been outside the scope of drug discovery. The present study suggests that molecular aggregation is a vast area to be explored for drug discovery and development because aggregates of small-molecule compounds can inhibit disease-related enzymes.
Collapse
Affiliation(s)
- Kenta Morita
- Department
of Chemical Science and
Engineering, Graduate School of Engineering, Kobe University 1-1 Rokkodai, Nada-ku, Kobe 657-8501, Japan
- Research
Center for Membrane and Film Technology, Kobe University, 1-1
Rokkodai, Nada-ku, Kobe 657-8501, Japan
| | - Tomoko Moriwaki
- Department
of Chemical Science and
Engineering, Graduate School of Engineering, Kobe University 1-1 Rokkodai, Nada-ku, Kobe 657-8501, Japan
| | - Shunsuke Habe
- Department
of Chemical Science and
Engineering, Graduate School of Engineering, Kobe University 1-1 Rokkodai, Nada-ku, Kobe 657-8501, Japan
| | - Mariko Taniguchi-Ikeda
- Department
of Clinical Genetics, Fujita Health University
Hospital 1-98 Dengakugakubo, Kutsukake-chou, Toyoake, Aichi 470-1192, Japan
| | - Tadao Hasegawa
- Department
of Bacteriology, Graduate School of Medical
Sciences, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan
| | - Yusuke Minato
- Department
of Microbiology, School of Medicine, Fujita
Health University, 1-98
Dengakugakubo, Kutsukake-chou, Toyoake, Aichi 470-1192, Japan
| | - Takashi Aoi
- Division
of Stem Cell Medicine, Graduate School of Medicine, Kobe University, 7-5-1
Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
| | - Tatsuo Maruyama
- Department
of Chemical Science and
Engineering, Graduate School of Engineering, Kobe University 1-1 Rokkodai, Nada-ku, Kobe 657-8501, Japan
- Research
Center for Membrane and Film Technology, Kobe University, 1-1
Rokkodai, Nada-ku, Kobe 657-8501, Japan
| |
Collapse
|
2
|
Scioli G, Marinaccio L, Bauer M, Kamysz W, Parmar A, Newire E, Singh I, Stefanucci A, Mollica A. New Teixobactin Analogues with a Total Lactam Ring. ACS Med Chem Lett 2023; 14:1827-1832. [PMID: 38116416 PMCID: PMC10726481 DOI: 10.1021/acsmedchemlett.3c00435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2023] [Revised: 10/25/2023] [Accepted: 11/09/2023] [Indexed: 12/21/2023] Open
Abstract
Teixobactin is a new antibiotic peptide with strong efficacy against several Gram-positive resistant bacteria, the structure of which is extremely difficult to obtain in the laboratory via multistep conventional synthesis. To face the increasing antibiotic resistant bacteria, it is fundamental to introduce new types of antibiotics with innovative mechanisms of action without resistance; thus, many scientists are studying and developing new methods to synthesize teixobactin analogues. In this work, seven Arg10-teixobactin analogues with a total lactam ring have been prepared via solid phase peptide synthesis. In order to obtain the total lactam ring, d-Thr8 was replaced by (2R,3S)-diamino-propionic acid. To verify their antimicrobial activity and efficacy, each analogue was tested with MIC against different resistant pathogens, showing an interesting activity for Nle11 containing compounds.
Collapse
Affiliation(s)
- Giuseppe Scioli
- Department
of Pharmacy, University “G. d’Annunzio”
Chieti-Pescara, Via dei
Vestini 31, 66100 Chieti, Italy
| | - Lorenza Marinaccio
- Department
of Pharmacy, University “G. d’Annunzio”
Chieti-Pescara, Via dei
Vestini 31, 66100 Chieti, Italy
| | - Marta Bauer
- Department
of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, Poland
| | - Wojciech Kamysz
- Department
of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, Poland
| | - Anish Parmar
- Antimicrobial
Pharmacodynamics and Therapeutics, Department of Molecular and Clinical
Pharmacology, University of Liverpool, Sherrington Building, L69 3GA Liverpool, U.K.
- Department
of Chemistry, The Robert Robinson Laboratories, The University of Liverpool, L69 3BX Liverpool, United Kingdom
| | - Enas Newire
- Antimicrobial
Pharmacodynamics and Therapeutics, Department of Molecular and Clinical
Pharmacology, University of Liverpool, Sherrington Building, L69 3GA Liverpool, U.K.
- Department
of Chemistry, The Robert Robinson Laboratories, The University of Liverpool, L69 3BX Liverpool, United Kingdom
| | - Ishwar Singh
- Antimicrobial
Pharmacodynamics and Therapeutics, Department of Molecular and Clinical
Pharmacology, University of Liverpool, Sherrington Building, L69 3GA Liverpool, U.K.
- Department
of Chemistry, The Robert Robinson Laboratories, The University of Liverpool, L69 3BX Liverpool, United Kingdom
| | - Azzurra Stefanucci
- Department
of Pharmacy, University “G. d’Annunzio”
Chieti-Pescara, Via dei
Vestini 31, 66100 Chieti, Italy
| | - Adriano Mollica
- Department
of Pharmacy, University “G. d’Annunzio”
Chieti-Pescara, Via dei
Vestini 31, 66100 Chieti, Italy
| |
Collapse
|
3
|
Mirzakhanian A, Khoury M, Trujillo DE, Kim B, Ca D, Minehan T. DNA major versus minor groove occupancy of monomeric and dimeric crystal violet derivatives. Toward structural correlations. Bioorg Med Chem 2023; 94:117438. [PMID: 37757605 DOI: 10.1016/j.bmc.2023.117438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Revised: 08/05/2023] [Accepted: 08/07/2023] [Indexed: 09/29/2023]
Abstract
Six monomeric (1a-1f) and five dimeric (2a-2e) derivatives of the triphenylmethane dye crystal violet (CV) have been prepared. Evaluation of the binding of these compounds to CT DNA by competitive fluorescent intercalator displacement (FID) assays, viscosity experiments, and UV and CD spectroscopy suggest that monomeric derivative 1a and dimeric derivative 2d likely associate with the major groove of DNA, while dimeric derivatives 2a and 2e likely associate with the minor groove of DNA. Additional evidence for the groove occupancy assignments of these derivatives was obtained from ITC experiments and from differential inhibition of DNA cleavage by the major groove binding restriction enzyme BamHI, as revealed by agarose gel electrophoresis. The data indicate that major groove ligands may be optimally constructed from dye units containing a sterically bulky 3,5-dimethyl-N,N-dimethylaniline group; furthermore, the groove-selectivity of olefin-tethered dimer 2d suggests that stereoelectronic interactions (n → π*) between the ligand and DNA are also an important design consideration in the crafting of major-groove binding ligands.
Collapse
Affiliation(s)
- Aren Mirzakhanian
- Department of Chemistry and Biochemistry, California State University, Northridge, 18111 Nordhoff Street, Northridge, CA 91330, USA
| | - Michael Khoury
- Department of Chemistry and Biochemistry, California State University, Northridge, 18111 Nordhoff Street, Northridge, CA 91330, USA
| | - Donald E Trujillo
- Department of Chemistry and Biochemistry, California State University, Northridge, 18111 Nordhoff Street, Northridge, CA 91330, USA
| | - Byoula Kim
- Department of Chemistry and Biochemistry, California State University, Northridge, 18111 Nordhoff Street, Northridge, CA 91330, USA
| | - Donnie Ca
- Department of Chemistry and Biochemistry, California State University, Northridge, 18111 Nordhoff Street, Northridge, CA 91330, USA
| | - Thomas Minehan
- Department of Chemistry and Biochemistry, California State University, Northridge, 18111 Nordhoff Street, Northridge, CA 91330, USA.
| |
Collapse
|
4
|
Zhang XC, Chang N, Zhang XQ. Orthogonal threading-through-β-sheet design of lung cancer EGFR extracellular domain-derived peptidic mimotopes binding to anti-EGFR antibody. Chem Biol Drug Des 2023; 101:848-854. [PMID: 36471585 DOI: 10.1111/cbdd.14188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2022] [Revised: 11/15/2022] [Accepted: 12/01/2022] [Indexed: 12/12/2022]
Abstract
Human epidermal growth factor receptor (EGFR) has been established as a therapeutic target of lung cancer and other diverse tumors. The antibody drug Cetuximab has been developed to target the third subdomain III (TSDIII) of EGFR extracellular domain (ECD) by competitively inhibiting epidermal growth factor binding. In this study, we performed systematic investigation on the crystal complex structure of EGFR ECD domain with Cetuximab to create a residue importance profile for the TSDIII subdomain, based on which a number of U-shaped, double-stranded linear peptides were derived and cyclized to orthogonally thread through most hotspot residues and many responsible residues within the TSDIII β-sheet plane; they represent mimotopes of the key antibody-recognition site of TSDIII subdomain. Computational analyses revealed that these linear peptides cannot spontaneously fold to the desired conformation in free state due to their intrinsic flexibility. Cell-free assays confirmed that the stapling can considerably improve the binding affinity of linear peptides to Cetuximab by up to 18-fold. The cOrt1 [3-18] cyclic peptide was measured to have the highest affinity in all designed linear and cyclic peptides.
Collapse
Affiliation(s)
- Xian-Chao Zhang
- Department of Oncology, Xintai People's Hospital affiliated to Qilu Medical University, Xintai, China
| | - Na Chang
- Department of Imaging, Jinan Vocational College of Nursing, Jinan, China
| | - Xian-Qi Zhang
- Department of Thoracic Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, China
| |
Collapse
|
5
|
A novel nucleic acid-binding protein, Gp49, from mycobacteriophage with mycobactericidal activity has the potential to be a therapeutic agent. Int J Biol Macromol 2023; 236:124025. [PMID: 36921817 DOI: 10.1016/j.ijbiomac.2023.124025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2023] [Revised: 03/07/2023] [Accepted: 03/08/2023] [Indexed: 03/14/2023]
Abstract
The mycobacteriophages encode unique proteins that are potent to be therapeutic agents. We screened several clones with mycobactericidal properties from a genomic library of mycobacteriophages. Here we report the properties of one such clone coding the gene product, Gp49, of the phage Che12. Gp49 is a 16 kD dimeric protein having an HTH motif at its C-terminal and is highly conserved among mycobacteriophages and likely to be part of phage DNA replication machinery. Alphafold predicts it to be an α-helical protein. However, its CD spectrum showed it to be predominantly β-sheeted. It is a high-affinity heparin-binding protein having similarities with the macrophage protein Azurocidin. Its β-sheeted apo-structure gets transformed into α-helix upon binding to heparin. It binds to linear dsDNA as well as ssDNA and RNA cooperatively in a sequence non-specific manner. This DNA binding property enables it to inhibit both in vitro and in vivo transcription. The c-terminal HTH motif is responsible for binding to both heparin and nucleic acids. Its in vivo localization on DNA could cause displacements of many DNA-binding proteins from the bacterial chromosome. We surmised that the bactericidal activity of Gp49 arises from its non-specific DNA binding leading to the inhibition of many host-DNA-dependent processes. Its heparin-binding ability could have therapeutic/diagnostic usages in bacterial sepsis treatment.
Collapse
|
6
|
Xu M, Zhou B, Ding Y, Du S, Su M, Liu H. Programmable Oligonucleotide-Peptide Complexes: Synthesis and Applications. Chem Res Chin Univ 2022. [DOI: 10.1007/s40242-021-1265-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
7
|
Nosrati M, Roushani M. Three-dimensional modeling of streptomycin binding single-stranded DNA for aptamer-based biosensors, a molecular dynamics simulation approach. J Biomol Struct Dyn 2022; 41:3430-3439. [PMID: 35297324 DOI: 10.1080/07391102.2022.2050945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Streptomycin (STR) an aminoglycoside antibiotic which is used against bacteria in human and animal infection, have serious side effects on different parts of human body. Therefore, there is a crucial need to detect trace amount of it in serum and food products. Aptamers are oligonucleotides or peptides, which bind their targets with high affinity and specificity. These properties make aptamers as suitable candidates for biosensing applications. A 79-mer ss-DNA aptamer was applied for the detection of small amount of STR in various aptasensors. But there is no structural information on the STR-binding aptamer and molecular details underlying the aptamer-STR binding remain unexplored. In this study we provided a 3D-structural model for 79-mer ss-DNA aptamer from the sequence. Using docking program and molecular dynamics (MD) simulation we predicted the binding pocket of ss-DNA aptamer. Our results show STR streptose ring is buried within the groove of DNA model and capped by non Watson-Crick bases. STR interacts with aptamer through forming stable hydrogen bonds. Our computational findings are in fair agreement with experimental results. With the atomic structural details, we gained new insight into the Apt-STR binding interaction that can help to further optimize aptamer efficiency in biosensing applications.Communicated by Ramaswamy H. Sarma.
Collapse
|
8
|
Antitumor and apoptotic effects of new-generation platinum compounds on human leukemia cell lines HL-60 and K562. Biologia (Bratisl) 2021. [DOI: 10.1007/s11756-021-00930-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
9
|
Selective MOR activity of DAPEA and Endomorphin-2 analogues containing a (R)-γ-Freidinger lactam in position two. Bioorg Chem 2021; 115:105219. [PMID: 34343741 DOI: 10.1016/j.bioorg.2021.105219] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Revised: 07/17/2021] [Accepted: 07/24/2021] [Indexed: 12/12/2022]
Abstract
The use of α-amino-γ lactam of Freidinger (Agl) may serve as an impressive method to increase the biological stability of peptides and an appropriate tool to elucidate their structure-activity relationships. The endomorphin-2 (EM-2) and [D-Ala2, des-Leu5] enkephalin amide (DAPEA) are two linear opioid tetrapeptides agonists of MOR and MOR/DOR respectively. Herein, we investigated the influence of the incorporation of (R/S)-Agl in position 2 and 3 on the biological profile of the aforementioned products in vitro and in vivo. Receptor radiolabeled displacement and functional assays were used to measure in vitro the binding affinity and receptors activation of the novel analogues. The mouse tail flick and formalin tests allowed to observe their antinociceptive effect in vivo. Data revealed that peptide A2D was able to selectively bind and activate MOR with a potent antinociceptive effect after intracerebroventricular (i.c.v.) administration, performing better than the parent compounds EM-2 and DAPEA. Molecular docking calculations helped us to understand the key role exerted by the Freidinger Agl moiety in A2D for the interaction with the MOR binding pocket.
Collapse
|